E2F-1 Induces Melanoma Cell Apoptosis Via PUMA Up-regulation and Bax Translocation
Overview
Authors
Affiliations
Background: PUMA is a pro-apoptotic Bcl-2 family member that has been shown to be involved in apoptosis in many cell types. We sought to ascertain whether induction of PUMA plays a crucial role in E2F-1-induced apoptosis in melanoma cells.
Methods: PUMA gene and protein expression levels were detected by real-time PCR and Western blot in SK-MEL-2 and HCT116 cell lines after Ad-E2F-1 infection. Activation of the PUMA promoter by E2F-1 overexpression was detected by dual luciferase reporter assay. E2F-1-induced Bax translocation was shown by immunocytochemistry. The induction of caspase-9 activity was measured by caspase-9 colorimetric assay kit.
Results: Up-regulation of the PUMA gene and protein by E2F-1 overexpression was detected by real-time PCR and Western blot analysis in the SK-MEL-2 melanoma cell line. In support of this finding, we found six putative E2F-1 binding sites within the PUMA promoter. Subsequent dual luciferase reporter assay showed that E2F-1 expression could increase the PUMA gene promoter activity 9.3 fold in SK-MEL-2 cells. The role of PUMA in E2F-1-induced apoptosis was further investigated in a PUMA knockout cell line. Cell viability assay showed that the HCT116 PUMA-/- cell line was more resistant to Ad-E2F-1-mediated cell death than the HCT116 PUMA+/+ cell line. Moreover, a 2.2-fold induction of the PUMA promoter was also noted in the HCT116 PUMA+/+ colon cancer cell line after Ad-E2F-1 infection. Overexpression of a truncated E2F-1 protein that lacks the transactivation domain failed to up-regulate PUMA promoter, suggesting that PUMA may be a transcriptional target of E2F-1. E2F-1-induced cancer cell apoptosis was accompanied by Bax translocation from the cytosol to mitochondria and the induction of caspase-9 activity, suggesting that E2F-1-induced apoptosis is mediated by PUMA through the cytochrome C/Apaf-1-dependent pathway.
Conclusion: Our studies strongly demonstrated that E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation. The signaling pathways provided here will further enhance insights on the mechanisms of E2F-1-induced cancer cell apoptosis as a strategy for cancer therapy.
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis.
Neuendorf H, Simmons J, Boyle G Front Cell Dev Biol. 2023; 11:1183328.
PMID: 37181747 PMC: 10169659. DOI: 10.3389/fcell.2023.1183328.
A comprehensive review of the roles of E2F1 in colon cancer.
Fang Z, Lin M, Li C, Liu H, Gong C Am J Cancer Res. 2020; 10(3):757-768.
PMID: 32266089 PMC: 7136928.
Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang A, Qian H, Zhang T, Zhou N, Wang H, Men X Drug Des Devel Ther. 2015; 9:5671-86.
PMID: 26527862 PMC: 4621185. DOI: 10.2147/DDDT.S90082.
Sharma S, Sarkar J, Haldar C, Sinha S PLoS One. 2014; 9(9):e108602.
PMID: 25259610 PMC: 4178181. DOI: 10.1371/journal.pone.0108602.
Clavier A, Baillet A, Rincheval-Arnold A, Coleno-Costes A, Lasbleiz C, Mignotte B Cell Death Dis. 2014; 5:e1405.
PMID: 25188515 PMC: 4540203. DOI: 10.1038/cddis.2014.372.